Case Study
Nature Highlights Baker Lab's New Breakthrough: Single-Protein Artificial Virus-Like Particles Reach 220 nm in Diameter

Inquiry
Nature Highlights Baker Lab's New Breakthrough: Single-Protein Artificial Virus-Like Particles Reach 220 nm in Diameter

Nature Highlights Baker Lab's New Breakthrough: Single-Protein Artificial Virus-Like Particles Reach 220 nm in Diameter

CD ComputaBio provides cutting-edge software-based virtual services to empower researchers, but we do not offer free software packages.

Overview

This work addresses a long-standing protein design challenge: how to build large, virus-like, closed protein assemblies from a single genetically encoded building block. Natural viruses solve this problem through quasisymmetry, placing chemically identical subunits into symmetry-inequivalent local environments. The study shows that similar behavior can be engineered by designing building blocks with programmed curvature and strong interactions, allowing spontaneous symmetry breaking to close large cages.

By combining a parametric description of cage geometry with RoseTTAFold diffusion-based generative modeling, the authors designed a broad set of one-component quasisymmetric protein nanocages. Electron microscopy validated cages with triangulation numbers from T=3 to T=36, containing 180 to 2,160 subunits and spanning approximately 68 to 220 nm in diameter. The results provide a design route for large protein assemblies that may be useful in biologic delivery, vaccine antigen display, and other nanoscale biomaterials applications.

Translated Abstract

Background: Why Large One-Component Assemblies Are Difficult to Design

The largest fully symmetric closed assembly built from a single protein building block is typically a 60-subunit icosahedron. Natural viruses overcome this size limit through quasisymmetry, allowing hundreds to thousands of identical subunits to form large capsids.

In these viral capsids, the same protein subunit can occupy different local environments and adopt slightly different conformations. This gives viruses large internal volume while still using only one building block.

For biologic delivery, this is highly attractive because a large, single-component cage could simplify design, production, and cargo packaging. However, such systems are difficult to engineer because identical subunits must form different interactions in different positions within the same assembly.

Design Concept

The authors proposed that quasisymmetry could arise through spontaneous symmetry breaking when strongly interacting building blocks are designed with programmed curvature.

To test this idea, they combined:

  • Parametric cage representations
  • RoseTTAFold diffusion-based generative modeling
  • Computational design of curved protein building blocks
  • Experimental structural validation

Figure 1. Quasisymmetry design parameter space. Geometric and energetic parameters that define the design landscape.Figure. 1 Quasisymmetry design parameter space.

Overall Significance

The work demonstrates that complex quasisymmetric structures can be created by designing system-level properties rather than only individual protein-protein interfaces. It provides a roadmap for engineering large artificial virus-like assemblies that may be useful for biologic delivery, nanomaterials, and other protein-based technologies.

Research Background

1. Research Question

This study investigates how to design single-component, quasisymmetric protein nanocages. Although a fully symmetric 60-subunit icosahedron represents the largest closed assembly that can be formed from a single building block under strict symmetry, many viruses overcome this limitation through quasisymmetry, enabling capsid assemblies composed of hundreds to thousands of identical subunits.

Quasisymmetric single-component assemblies are attractive for biomedical delivery applications because they can generate larger internal volumes while retaining the genetic and manufacturing simplicity of a single building block. However, designing such structures is challenging because chemically identical subunits must be able to adopt different conformations and participate in different local interaction environments within the same closed assembly.

2. Research Challenges

The main challenges of this study include designing chemically identical subunits that can occupy symmetry-nonequivalent positions with distinct conformations and interactions, and achieving global symmetry breaking in a controlled way to form large, complex quasisymmetric assemblies.

In other words, the design must balance local interaction strength, geometric compatibility, and overall cage closure. If the interactions are too rigid, the assembly may fail to close. If they are too flexible or nonspecific, the product may become heterogeneous or poorly defined.

3. Related Work

Related work includes the structural study of viral capsids and the computational design of protein nanomaterials. In a perfect icosahedral assembly, 2-fold, 3-fold, and 5-fold symmetry axes define a highly regular architecture. In many designed and naturally occurring icosahedral protein assemblies, trimeric building blocks are positioned on 3-fold symmetry axes, so all 60 subunits experience equivalent chemical environments.

To increase the capacity for packaging genetic material while preserving the economy of genetic encoding, many viruses expand beyond this fully symmetric architecture by inserting additional subunits into hexagonal environments. This produces larger capsids that are still composed of the same protein subunit but arranged in symmetry-nonequivalent local environments.

Research Methods

This paper proposes a design strategy for high-T-number quasisymmetric protein cages.

1. Parametric Design

  • The authors first defined two structural parameters to describe the interaction geometry between trimeric building blocks: φ and θ. The parameter φ represents the angle between vectors drawn from one trimer centroid to its two nearest neighboring trimers. The parameter θ describes the angle between trimer vectors and reflects the curvature of the lattice.
  • Together, these two parameters define a two-dimensional design space. This parameter space spans structures ranging from fully symmetric T=1 icosahedral cages and flat two-dimensional hexagonal lattices to larger high-T-number quasisymmetric protein cages.

2. Assembly Strategy

  • The design strategy uses C3-symmetric homotrimers as the primary building blocks. These trimers are positioned at target locations through defined rotation and translation operations. A C2 building block is then placed between two neighboring trimers.
  • Next, RFdiffusion is used to generate a new protein backbone that rigidly connects the C2 and C3 subunits. This approach creates a single-chain protein design that can assemble through programmed trimer-trimer interactions into larger quasisymmetric architectures.

3. Energy-Driven Symmetry Breaking

  • The study assumes that, in a strongly interacting building-block system, symmetry breaking can arise spontaneously because closed cage formation provides an energetic benefit. This energetic gain may help release geometric strain and enable the assembly to close.
  • As a result, the same building block may adopt multiple local conformational states, such as pentagonal-edge and hexagonal-edge environments. This provides a possible mechanism for forming large high-T-number assemblies from a single protein component.

Experimental Design

Protein Expression and Purification

The designed plasmids were transformed into chemically competent E. coli BL21(DE3) expression cells and cultured at 37°C. After expression, the cells were disrupted by sonication. The target proteins were first purified using Ni-NTA affinity chromatography and then further purified by size-exclusion chromatography.

Negative-Stain Electron Microscopy

Purified protein samples were analyzed by negative-stain electron microscopy to observe particle morphology and evaluate whether the designed proteins formed cage-like assemblies consistent with quasisymmetric organization.

Cryo-Electron Microscopy

Cryo-EM data were collected using Titan Krios and Glacios microscopes operated at 300 kV and 200 kV, respectively. The authors then performed image processing and subvolume analysis to reconstruct three-dimensional structures and further examine the organization of the designed assemblies.

Results and Analysis

01 Design and Testing of Symmetric Assemblies

  • The authors first designed and tested symmetric assemblies located at the boundaries of the design parameter space, including T=1 icosahedral cages and two-dimensional hexagonal lattices. These structures served as reference systems to evaluate whether the geometric design strategy could reliably generate the intended assembly states.
  • Experimental results showed that the designed proteins successfully formed the expected two-dimensional hexagonal lattices and T=1 icosahedral cages. This confirmed that the parameterized design framework could control both flat lattice formation and closed symmetric cage assembly.

Figure 2. nsEM characterization of high-T-number assemblies. Morphological assessment of assemblies with elevated triangulation numbers.Figure. 2 nsEM characterization of high triangulation number assemblies.

02 Design of High-T-Number Quasisymmetric Protein Cages

  • By tuning the two geometric parameters, φ and θ, the authors designed high-T-number quasisymmetric protein cages, including T=3 and T=13 architectures. These designs were intended to test whether the same single-component building block could support larger assemblies with symmetry-nonequivalent local environments.
  • Negative-stain electron microscopy and cryo-electron microscopy showed that the designed protein cages formed quasisymmetric assemblies with different shapes and sizes. These results suggest that the design approach can extend beyond simple symmetric cages and generate larger, virus-like protein architectures.

Figure 3. Cryo-EM analysis of symmetry breaking in dQS_T3. Structural dissection of the dQS_T3 variant reveals deviations from perfect quasisymmetry.Figure. 3 Cryo-EM analysis of symmetry breaking in the dQS_T3 structure.

03 Cryo-EM Analysis of Large Quasisymmetric Cages

  • Cryo-EM analysis of the high-T-number quasisymmetric protein cages showed that the designed assemblies had diameters ranging from approximately 120 nm to 220 nm. These particle sizes corresponded to assemblies containing about 780 to 2,160 protein subunits.
  • The larger high-T-number cages showed greater structural heterogeneity. This may be because neighboring T-number architectures occupy very similar regions of the geometric parameter space. As a result, small variations in local geometry or assembly pathway may lead to related but non-identical cage sizes and shapes.
  • Overall, the results demonstrate that single-component protein designs can form large quasisymmetric nanocages, although higher T-number assemblies remain more difficult to control than smaller symmetric or low-T-number structures.

Figure 4. Quasisymmetric design space from T = 1 to T = 3. A systematic mapping of structural transitions across the T-number continuum.Figure. 4 Quasisymmetric design space between T = 1 and T = 3.

Why It Matters?

The main advance is not just another protein nanoparticle, but a system-level protein design principle. Instead of explicitly optimizing every symmetry-inequivalent local environment, the method designs global curvature and interaction strength so that the assembly finds the required local states during closure. This is conceptually close to how viral capsids use repeated subunits to build large containers.

For biotechnology, the work points toward programmable artificial virus-like particles that can be built from a single protein sequence. Such systems could simplify manufacturing, increase internal cargo volume, and create modular platforms for drug delivery, vaccine antigen display, gene-delivery research, or nanoscale material construction.

Limitations and Outlook

The article also implies important remaining challenges. High-T cages showed greater heterogeneity, which may limit applications that require strict monodispersity, reproducible cargo loading, or predictable in vivo behavior. Additional optimization will likely be needed for particle uniformity, expression yield, assembly robustness, cargo encapsulation, surface functionalization, and safety-related properties such as aggregation, biodistribution, and immunogenicity.

Future development will need to connect computational protein assembly design with experimental characterization and application-specific engineering. For therapeutic delivery, the key next questions are not only whether a cage forms, but whether it can package cargo, remain stable in formulation, avoid unwanted immune responses, and deliver its payload to the intended cell type or tissue.

Overview of What CD ComputaBio Can Provide

Programs inspired by this article require coordination among protein modeling, assembly-interface engineering, particle stability analysis, delivery-system design, and immune-risk evaluation. CD ComputaBio supports research-stage projects that connect computational protein assembly design with practical validation and application decisions. The following related capabilities were selected from the attached website outline because they directly match the technical decisions discussed on this page.

Research Need Related CD ComputaBio Support How It Connects to This Research
Evaluating designed cage architectures Protein Structure Modeling Service Helps assess whether designed subunits and assemblies are structurally plausible enough for downstream interface and stability analysis.
Engineering subunit-subunit interfaces Protein-Protein Docking Service Connects directly to the need to position C2/C3 building blocks and evaluate designed protein-protein interfaces.
Mapping assembly contact hot spots Protein-Protein Interactions Analysis Service Identifies interface residues and interaction patterns that may control pentamer/hexamer formation and cage closure.
Testing cage stability and flexibility Molecular Dynamics Simulation Service Supports dynamic evaluation of protein cages, interface persistence, conformational strain, and stability under formulation-relevant conditions.
Checking foldability of designed subunits Protein Foldability Verification Helps screen de novo proteins for likely folding success before committing to expression and assembly experiments.
Optimizing mutations for assembly quality Protein Mutation Effect Modeling Prioritizes substitutions that may improve folding, interface strength, particle uniformity, or thermal stability.
Adapting particles for biologic cargo delivery Drug Delivery System Design Service Connects protein cage design to cargo loading, delivery format, formulation, and application-specific translational questions.
Exploring vaccine-display applications Protein Vaccine Design Service Supports antigen-display concepts that use ordered protein nanoparticles or virus-like particles as immune-presentation scaffolds.

Contact Us

If you are exploring de novo protein cage design, artificial virus-like particles, protein assembly engineering, or delivery-oriented nanoparticle optimization, CD ComputaBio can help translate early design concepts into practical computational workflows. Our team supports protein structure modeling, protein-protein interface analysis, molecular dynamics simulation, mutation effect evaluation, and delivery-system design to help researchers assess whether a designed assembly is structurally plausible, stable, and suitable for downstream experimental validation. Contact us to discuss your project goals and identify the most appropriate computational strategy for your protein nanoparticle or biologic delivery research.

Reference:

  1. Lee S, Chmielewski D, Wang S, et al. Design of one-component quasisymmetric protein nanocages. Nature, 2026: 1-7. https://doi.org/10.1038/s41586-026-10554-z
* For Research Use Only.
Related Services

Online Inquiry

Submit your project details below, and our team will respond within 24 hours.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk
Copyright © CD ComputaBio. All Rights Reserved.
Top